NCT01070719View on ClinicalTrials.gov

Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort

CompletedOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Multiple SclerosisRelapse
Trial Locations (1)

84103

Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

John F. Foley, MD

OTHER